Indian Institute of Public Health-Delhi, Gurgaon, India.
Department of Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Heart Lung Circ. 2019 Dec;28(12):1788-1794. doi: 10.1016/j.hlc.2018.10.024. Epub 2018 Dec 10.
Statins are the most widely prescribed hypolipidaemic drugs for coronary artery disease (CAD) patients, but have been found to cause muscle and nerve related adverse effects which can affect patient satisfaction with treatment. Literature on treatment satisfaction among statin users, especially from resource-limited settings is inadequate. The aim of this cross-sectional study was to assess the level of satisfaction with treatment among statin users and evaluate the relationship between adverse effects experienced by patients and their satisfaction with the medication.
This study included 300 adult CAD patients visiting the cardiology department of a tertiary care hospital in the northern region of India, who were prescribed statins for their diagnoses. An interviewer administered, validated and standardised Treatment Satisfaction Questionnaire for Medication (version 1.4) was used for data collection.
Around three quarters of the population reported being overall satisfied with their medication. Mean scores were calculated for Effectiveness, Convenience, Side-Effects and Global Satisfaction. The patients reported high scores (above 60%) for all domains. Those experiencing any adverse effect were found to be more likely to report lower effectiveness. Additionally, medication effectiveness showed a positive correlation with overall treatment satisfaction.
The study shows that treatment satisfaction is critical to gauge patient experiences with the treatment which can impact medication adherence and compliance. It's a crucial measure especially among CAD and other chronic disease patients since greater satisfaction can improve clinical outcomes. More research is warranted to better understand the relationship between medication effectiveness and treatment satisfaction.
他汀类药物是治疗冠心病 (CAD) 患者最常用的降脂药物,但已发现其会引起肌肉和神经相关的不良反应,从而影响患者对治疗的满意度。关于他汀类药物使用者治疗满意度的文献,特别是来自资源有限环境的文献不足。本横断面研究旨在评估他汀类药物使用者的治疗满意度水平,并评估患者经历的不良反应与他们对药物的满意度之间的关系。
本研究纳入了 300 名在印度北部一家三级保健医院心内科就诊的成年 CAD 患者,他们因诊断而开了他汀类药物。使用经过验证和标准化的治疗满意度问卷(第 1.4 版)来进行数据收集。
约四分之三的人群报告对其药物总体满意。对有效性、便利性、副作用和总体满意度进行了平均评分。患者在所有领域的评分均较高(高于 60%)。那些经历任何不良反应的人更有可能报告较低的有效性。此外,药物有效性与总体治疗满意度呈正相关。
该研究表明,治疗满意度是衡量患者对治疗体验的关键指标,这可能会影响药物的依从性。对于 CAD 和其他慢性疾病患者来说,这是一个至关重要的衡量标准,因为更高的满意度可以改善临床结果。需要进一步研究以更好地了解药物有效性和治疗满意度之间的关系。